Skip to content
Disclosery

ORBIMED ADVISORS LLC: CAI position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of ORBIMED ADVISORS LLC on CAI, newest first. How the timeline and the estimate are built.

ORBIMED ADVISORS LLC held 2,806,811 CAI shares at 2026-06-30 per its 13F-HR filed 2026-08-14.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 2,806,811 shares
    Change vs previous 13F 0 shares

    0.95% of the 13F portfolio, value $50,017,372.

    13F-HR 0001172661-26-003740 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 2,806,811 shares
    Change vs previous 13F -309,200 shares

    1.09% of the 13F portfolio, value $50,185,781.

    13F-HR 0001172661-26-002369 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 3,116,011 shares
    Change vs previous 13F +81,153 shares

    1.72% of the 13F portfolio, value $84,069,977.

    13F-HR 0001172661-26-001119 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 3,034,858 shares
    Change vs previous 13F 0 shares

    2.2% of the 13F portfolio, value $91,804,455.

    13F-HR 0001172661-25-005047 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-06-30
    13F 3,034,858 shares
    Change vs previous 13F not available

    2.04% of the 13F portfolio, value $81,091,406.

    13F-HR 0001172661-25-003514 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).